Examining treatment targets and equity in bone-active medication use within secondary fracture prevention: a systematic review and meta-analysis
Study context
- Population
- Fragility fracture patients screened in secondary fracture prevention programs122 studies · 114 programs
- Outcome
- Proportion of patients indicated for treatment who received prescriptions and/or initiated bone-active medication
Methodological detailssingle group proportional meta-analysis
- Single group proportional meta-analysis
Pooled result
As reported in the abstract
Bone-active medication prescription and initiation (pooled proportions)
Pooled prescription rate
77%
Estimated medication initiation rate
71%
Further pooled results
Treatment initiation, Fracture Liaison Service vs other programs (subgroup)
- No significant difference in treatment initiation between the Fracture Liaison Service and other programs
Equity variables reported
- Age, sex and socioeconomic status were the only equity variables reported in relation to treatment outcomes
Original publication
Examining treatment targets and equity in bone-active medication use within secondary fracture prevention: a systematic review and meta-analysis. Osteoporos Int. Published 14 May 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →